Vimal Mehta, CEO, President, Secretary at BioXcel Therapeutics, Inc. (BTAI), bought 1,000 shares at $5.04 ($5K) on 2018-11-30, disclosed to the SEC on 2018-11-30.
Open-market purchase of $5k BTAI by CEO, President, Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.04 | 300 | $2K | 29.6% |
| 2 | $5.05 | 300 | $2K | 29.7% |
| 3 | $5.17 | 100 | $517 | 10.1% |
| 4 | $5.20 | 300 | $2K | 30.6% |
| Total | $5.10 avg | 1,000 | $5K | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |